{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:30:09Z","timestamp":1790735409693,"version":"4.1.0"},"reference-count":61,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,8,3]]},"DOI":"10.3233\/jad-160345","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T11:37:51Z","timestamp":1470310671000},"page":"893-905","source":"Crossref","is-referenced-by-count":47,"title":["Chronic Cerebral Hypoperfusion Accelerates Alzheimer\u2019s Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model"],"prefix":"10.1177","volume":"53","author":[{"given":"Yun","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Morihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160345_ref1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer\u2019s disease and vascular dementia in developing countries: Prevalence, management, and risk factors","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160345_ref2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ggi.12492","article-title":"Characteristic features of cognitive, affective and daily living functions of late-elderly dementia","volume":"16","author":"Hishikawa","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-160345_ref3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: An update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-160345_ref4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jns.2014.09.012","article-title":"Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer\u2019s disease and reverting to normal cognition","volume":"346","author":"Tokuchi","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160345_ref5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2009.02.053","article-title":"Resting cerebral blood flow, attention, and aging","volume":"1267","author":"Bertsch","year":"2009","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160345_ref6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jalz.2010.04.004","article-title":"Advances in perfusion magnetic resonance imaging in Alzheimer\u2019s disease","volume":"7","author":"Chen","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160345_ref7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JAD-2010-090700","article-title":"Primary cerebral blood flow deficiency and Alzheimer\u2019s disease: Shadows and lights","volume":"23","author":"Mazza","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160345_ref8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.1997.tb48461.x","article-title":"Cerebrovascular hypoperfusion: A risk factor for Alzheimer\u2019s disease? Animal model and postmortem human studies","volume":"826","author":"De Jong","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160345_ref9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: Nosological evidence","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"key":"10.3233\/JAD-160345_ref10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160345_ref11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-160345_ref12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-160345_ref13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.3233\/JAD-160345_ref14","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.023","article-title":"Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat","volume":"23","author":"Kurata","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.3233\/JAD-160345_ref15","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160345_ref16","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.STR.0000143725.19053.60","article-title":"White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion","volume":"35","author":"Shibata","year":"2004","journal-title":"Stroke"},{"key":"10.3233\/JAD-160345_ref17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease: A randomised trial","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"Lancet"},{"key":"10.3233\/JAD-160345_ref18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","article-title":"Galantamine treatment of vascular dementia: A randomized trial","volume":"69","author":"Auchus","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-160345_ref19","first-page":"743","article-title":"Nicotinic acetylcholine receptor in Alzheimer\u2019s disease","volume":"71","author":"Abe","year":"2013","journal-title":"Nihon Rinsho"},{"key":"10.3233\/JAD-160345_ref20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3565(25)12928-5","article-title":"Pharmacological evaluation of novel Alzheimer\u2019s disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine","volume":"277","author":"Bores","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-160345_ref21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","article-title":"Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer\u2019s disease","volume":"49","author":"Maelicke","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-160345_ref22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/ggi.12488","article-title":"Cognitive and affective benefits of combination therapy with galantamine plus cognitive rehabilitation for Alzheimer\u2019s disease","volume":"16","author":"Tokuchi","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-160345_ref23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3233\/JAD-143084","article-title":"Combination therapy of cholinesterase inhibitor (donepezil or galantamine) plus memantine in the Okayama Memantine Study","volume":"45","author":"Matsuzono","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160345_ref24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.nrl.0000087722.46430.c4","article-title":"Update on Alzheimer drugs (galantamine)","volume":"9","author":"Raskind","year":"2003","journal-title":"Neurologist"},{"key":"10.3233\/JAD-160345_ref25","first-page":"CD004746","article-title":"Galantamine for vascular cognitive impairment","author":"Craig","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-160345_ref26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1523\/JNEUROSCI.21-05-01619.2001","article-title":"Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy","volume":"21","author":"Winkler","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160345_ref27","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.neurobiolaging.2008.01.017","article-title":"Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances","volume":"30","author":"Thal","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160345_ref28","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","article-title":"Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid","volume":"96","author":"Calhoun","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160345_ref29","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160345_ref30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jnr.21017","article-title":"Intrathecal injection of epidermal growth factor and fibroblast growth factor 2 promotes proliferation of neural precursor cells in the spinal cords of mice with mutant human SOD1 gene","volume":"84","author":"Ohta","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-160345_ref31","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/sj.mp.4001957","article-title":"Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories","volume":"12","author":"Heldt","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-160345_ref32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2010.11.067","article-title":"Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice","volume":"1371","author":"Kurata","year":"2011","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160345_ref33","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1523\/JNEUROSCI.4456-03.2004","article-title":"Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain","volume":"24","author":"Okamura","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160345_ref34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/jcbfm.1988.81","article-title":"Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200-110)","volume":"8","author":"Abe","year":"1988","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160345_ref35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3565(25)12091-0","article-title":"[3H]epibatidine labels nicotinic receptors in rat brain: An autoradiographic study","volume":"275","author":"Perry","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-160345_ref36","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1471-4159.1989.tb08556.x","article-title":"Effects of a new calcium channel blocker, KB-2796, on protein synthesis of the CA1 pyramidal cell and delayed neuronal death following transient forebrain ischemia","volume":"53","author":"Yoshidomi","year":"1989","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160345_ref37","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-160345_ref38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0925-9","article-title":"Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts","volume":"123","author":"Okamoto","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160345_ref39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","article-title":"Sporadic cerebral amyloid angiopathy: Pathology, clinical implications, and possible pathomechanisms","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160345_ref40","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/STROKEAHA.110.603399","article-title":"Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice","volume":"42","author":"Maki","year":"2011","journal-title":"Stroke"},{"key":"10.3233\/JAD-160345_ref41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1034\/j.1600-0463.2002.100509.x","article-title":"Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: Cellular responses and expression of cerebral amyloid angiopathy-associated proteins","volume":"110","author":"Wang","year":"2002","journal-title":"APMIS"},{"key":"10.3233\/JAD-160345_ref42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt6","article-title":"Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease","volume":"1","author":"Weller","year":"2009","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160345_ref43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.STR.29.3.695","article-title":"Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: Evidence for region-specific sensitivity and delayed damage","volume":"29","author":"Dijkhuizen","year":"1998","journal-title":"Stroke"},{"key":"10.3233\/JAD-160345_ref44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-8993(93)90021-E","article-title":"Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease","volume":"623","author":"Kawai","year":"1993","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160345_ref45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/01913129409023202","article-title":"Microvasculature in brain biopsy specimens from patients with Alzheimer\u2019s disease: An immunohistochemical and ultrastructural study","volume":"18","author":"Vinters","year":"1994","journal-title":"Ultrastruct Pathol"},{"key":"10.3233\/JAD-160345_ref46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00401-003-0738-6","article-title":"Cerebral amyloid angiopathy in the elderly: Vessel walls changes and relationship with dementia","volume":"106","author":"Zekry","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160345_ref47","first-page":"808353","article-title":"Pathophysiology of vascular remodeling in hypertension","volume":"2013","author":"Renna","year":"2013","journal-title":"Int J Hypertens"},{"key":"10.3233\/JAD-160345_ref48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","article-title":"Two types of sporadic cerebral amyloid angiopathy","volume":"61","author":"Thal","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-160345_ref49","first-page":"456","article-title":"Cholinergic modulation by opioid receptor ligands: Potential application to Alzheimer\u2019s disease","volume":"13","author":"Motel","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"10.3233\/JAD-160345_ref50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2004.11.042","article-title":"Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits","volume":"1033","author":"Geerts","year":"2005","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160345_ref51","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/01.STR.23.11.1623","article-title":"Effects in cats of inhibition of nitric oxide synthesis on cerebral vasodilation and endothelium-derived relaxing factor from acetylcholine","volume":"23","author":"Wei","year":"1992","journal-title":"Stroke"},{"key":"10.3233\/JAD-160345_ref52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/jcbfm.1990.68","article-title":"Selective electrical stimulation of postganglionic cerebrovascular parasympathetic nerve fibers originating from the sphenopalatine ganglion enhances cortical blood flow in the rat","volume":"10","author":"Suzuki","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160345_ref53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00229004","article-title":"Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats","volume":"89","author":"Tsuchiya","year":"1992","journal-title":"Exp Brain Res"},{"key":"10.3233\/JAD-160345_ref54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.3233\/JAD-160345_ref55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/aps.2009.37","article-title":"Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: Mechanistic considerations and clinical relevance","volume":"30","author":"Bencherif","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.3233\/JAD-160345_ref56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.00874.x","article-title":"Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer\u2019s disease (APPsw)","volume":"81","author":"Nordberg","year":"2002","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160345_ref57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.105.098566","article-title":"Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice","volume":"317","author":"Unger","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-160345_ref58","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1745-7254.2008.00819.x","article-title":"Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer\u2019s disease","volume":"29","author":"Guan","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"10.3233\/JAD-160345_ref59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euroneuro.2005.06.005","article-title":"Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model","volume":"16","author":"Van Dam","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3233\/JAD-160345_ref60","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.npp.1301256","article-title":"The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: Involvement of dopaminergic systems","volume":"32","author":"Wang","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-160345_ref61","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/syn.21698","article-title":"PET imaging of acetylcholinesterase inhibitor-induced effects on alpha4beta2 nicotinic acetylcholine receptor binding","volume":"67","author":"Hillmer","year":"2013","journal-title":"Synapse"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:10Z","timestamp":1777370590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":61,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160345","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]}}}